Press Releases

2021

Bluegrass Vascular Announces Publication Reporting Experience with Cardiac Resynchronization Therapy Device Lead Placement following Use of Surfacer System

April 20, 2021

  San Antonio, TX – Bluegrass Vascular Technologies, a private medical technology company focused on innovating lifesaving devices and methods for vascular access procedures, announced today the publication of a report documenting the clinical utility of the Surfacer System to gain venous access prior to the placement of cardiac resynchronization therapy (CRT) device leads in […]

2020

Bluegrass Vascular Announces Publication of Surfacer System SAVE Registry Results

October 9, 2020

  San Antonio, TX – Bluegrass Vascular Technologies (Bluegrass Vascular), a private medical technology company focused on innovating lifesaving devices and methods for vascular access procedures, announced today the publication of the results from the company’s prospective, multicenter SAVE (Surfacer® System to Facilitate Access in VEnous Occlusions) Registry in the Journal of Vascular and Interventional […]

Bluegrass Vascular Technologies Announces Publication of Surfacer System IDE Study Results

July 16, 2020

San Antonio, TX – July 16, 2020 – Bluegrass Vascular Technologies (Bluegrass Vascular), a private medical technology company focused on innovating lifesaving devices and methods for vascular access procedures, announced today the publication of the results of its prospective, multicenter SAVE-US (Surfacer® System to Facilitate Access in VEnous Occlusions – United States) study in the […]

Bluegrass Vascular Technologies Announces First U.S. Commercial Cases with the Surfacer® Inside-Out® Access Catheter System

May 15, 2020

Bluegrass Vascular Technologies (Bluegrass Vascular), a private medical technology company focused on innovating lifesaving devices and methods for vascular access procedures, is pleased to announce that the first U.S. commercial cases using the Surfacer® Inside-Out® Access Catheter System were completed at Santa Clara Valley Medical Center in San Jose, California. The procedures were performed by Ehab Sorial, […]

BVT Welcomes National Kidney Foundation’s Revamp of the Kidney Disease Outcomes Quality Initiative (KDOQI) Clinical Practice Guidelines for Vascular Access

April 14, 2020

Updated 2019 guidelines emphasize vessel preservation, aligns with the Surfacer® System’s “Don’t Go Left™” approach.   Bluegrass Vascular Technologies (Bluegrass Vascular), a private medical technology company focused on innovating lifesaving devices and methods for vascular access procedures, welcomes the recent publication of the 2019 Update to National Kidney Foundation’s Kidney Disease Outcomes Quality Initiative (KDOQI) […]

FDA Grants De Novo Clearance to Bluegrass Vascular Technologies for the Surfacer® Inside-Out® Access Catheter System

February 13, 2020

SAN ANTONIO, TX – February 11, 2020 – Bluegrass Vascular Technologies (Bluegrass Vascular), a private medical technology company focused on innovating lifesaving devices and methods for vascular access procedures, announced today that the U.S. Food and Drug Administration (FDA) has granted a De Novo classification order for its Surfacer® Inside-Out® Access Catheter System. The Surfacer […]

2019

American Journal of Kidney Diseases Publishes Positive Clinical Results in First Independent, Multicenter Study of the Surfacer® Inside-Out® Access Catheter System

December 19, 2019

Bluegrass Vascular Technologies (Bluegrass Vascular), a private medical technology company focused on innovating lifesaving devices and methods for vascular access procedures, announced today the publication of positive results associated with a clinical study involving the use of the Surfacer® Inside-Out® Access Catheter System in the peer-reviewed American Journal of Kidney Diseases. The publication highlights the […]

Journal of Vascular Access Publishes Positive Clinical Results for Bluegrass Vascular’s Surfacer® System

September 24, 2019

Bluegrass Vascular Technologies announced today the publication of positive results associated with the clinical use of the Surfacer® Inside-Out® Access Catheter System in the peer-reviewed Journal of Vascular Access (JVA).

Bluegrass Vascular Announces Enrollment Completion And Positive Results In U.S. Pivotal IDE Trial

June 4, 2019

Bluegrass Vascular Technologies (Bluegrass Vascular), a private medical technology company focused on innovating lifesaving devices and methods for vascular access procedures, announced today it has successfully completed enrollment of the SAVE-US (Surfacer® System to Facilitate Access in VEnous Occlusions – United States) pivotal trial evaluating the safety and efficacy of the Surfacer® Inside-Out® Access Catheter System in […]

Surfacer® Inside-Out® Access Catheter System to be Featured at 2019 Charing Cross (CX) International Annual Symposium

April 15, 2019

Bluegrass Vascular Technologies (Bluegrass Vascular), a private medical technology company focused on innovating lifesaving devices and methods for vascular access procedures, announced today events taking place at the Charing Cross (CX) International Symposium this week in London, United Kingdom on April 15-18, 2019. Leading clinicians will discuss experience with the Surfacer® Inside-Out® Access Catheter System. The Surfacer […]

2018

Bluegrass Vascular Announces Positive Results from Independent Study – Building on Growing Body of Evidence for Clinical Application of the Surfacer System

October 27, 2018

Bluegrass Vascular Technologies, a private medical technology company focused on innovating lifesaving devices and methods for vascular access, announced today its Surfacer® Inside-Out® Access Catheter System has demonstrated positive commercial use, consistently achieving central venous access in patients with upper body occlusions.

Bluegrass Vascular Announces Enrollment Completion of International Post-Market SAVE Registry with Early Positive Results

October 15, 2018

Bluegrass Vascular Technologies, a private medical technology company focused on innovating lifesaving devices and methods for vascular access, announced today it has successfully completed enrollment of its prospective, multicenter, post-CE Mark, international SAVE (Surfacer® System to Facilitate Access in VEnous Occlusions) Registry.

Bluegrass Vascular Welcomes First Reporting Standards for Thoracic Central Vein Obstruction

April 13, 2018

Bluegrass Vascular Technologies, a private medical technology company focused on innovating lifesaving devices and methods for vascular access, today welcomed the publication of the first reporting standards for thoracic central vein obstruction (TCVO) in the Journal of Vascular and Interventional Radiology (JVIR).

Bluegrass Vascular Announces Enrollment Of First Patients In U.S. Pivotal Trial

January 18, 2018

Bluegrass Vascular Technologies, a private medical technology company focused on innovating lifesaving devices and methods for vascular access, today announced the enrollment of its first patients in the SAVE-US (Surfacer® System to Facilitate Access in VEnous Occlusions – United States) pivotal trial.

2017

Surfacer® Inside-Out® Access Catheter System to be Showcased at CIRSE 2017 Annual Meeting

September 14, 2017

Bluegrass Vascular Technologies, a private medical technology company focused on innovating lifesaving devices and methods for vascular access, today announced its upcoming Surfacer® Inside-Out® Access Catheter System educational events scheduled to take place at the Cardiovascular and Interventional Radiological Society of Europe(CIRSE) 2017 Annual Meeting in Copenhagen, Denmark.

First Patients Enrolled in Bluegrass Vascular Post-Market SAVE Study

April 24, 2017

Bluegrass Vascular Technologies, Inc. announced today that it has successfully enrolled over one third of its patients in the company’s post-market SAVE (Surfacer® System to Facilitate Access in VEnous Occlusions) Clinical Study. The SAVE study is an international, prospective, multicenter clinical follow-up study designed to confirm clinical performance and safety of the Surfacer® Inside-Out® Access Catheter System, a novel device indicated for obtaining central venous access to facilitate catheter insertion into the central venous system in patients with chronically occluded veins.

Bluegrass Vascular Announces Strategic Relationship with Merit Medical

March 6, 2017

Bluegrass Vascular Technologies announced today that it is entering into a strategic relationship with Merit Medical Systems (Merit Medical), a leading manufacturer and marketer of proprietary disposable devices. The agreement will streamline European distribution of the recently CE mark approved Surfacer® Inside-Out® Access Catheter System and will provide funding to support the company’s efforts to secure FDA clearance for product sales in the U.S.

Merit Medical to market Bluegrass Vascular’s catheter system in Europe

March 6, 2017

Publication: FierceBiotech Bluegrass Vascular nabbed a CE mark for its “inside-out” central venous catheter last summer. Now, the company is tapping Merit Medical to “streamline” the distribution of the device in Europe. “We are very pleased to be partnering with Merit Medical, a prominent distributor of medical devices in Europe and the U.S. that shares […]

2016

Bluegrass Vascular Secures CE Mark Approval and Announces Successful Commercial Use of The Surfacer® Inside-Out® Access Catheter System

August 30, 2016

Bluegrass Vascular Technologies today announced that it has received CE Mark approval and is launching limited commercial sale of its Surfacer® Inside-Out® Access Catheter System. The Surfacer System is indicated for obtaining central venous access to facilitate catheter insertion into the central venous system via a novel Inside-Out approach.

Bluegrass Vascular Technologies Announces First Clinical Use of the Surfacer® Inside-Out® Access Catheter System in Europe

March 29, 2016

The Surfacer® Inside-Out Access® Catheter System procedure was performed under Germany’s “compassionate use” program,which grants access to physicians for use of medical devices not yet CE Mark approved in Europe, particularly in Germany, for patients who are diagnosed with advanced diseases and fail to respond to existing treatment options.

2014

Bluegrass Vascular Technologies Names Dr. Gabriele Niederauer President and CEO

September 2, 2014

Bluegrass Vascular today announced the appointment of Dr. Gabriele Niederauer, a seasoned senior medical device executive, to President and CEO. Following the recent closure of Series A financing, BVT is focused on obtaining CE Mark for the Surfacer™ Inside-Out™ Access Catheter System, a proprietary system that allows physicians to gain venous access using a novel approach.

Bluegrass Vascular Technologies Raises $4.5M Series A Financing Led by Targeted Technology Funds

July 31, 2014

Bluegrass Vascular today announced it has closed $4.5 million in Series A financing, which was led by Targeted Technology Fund II. Proceeds from the deal will allow Bluegrass Vascular to obtain CE Mark for the Surfacer™ Inside-Out™ Access Catheter System, enhance manufacturing capabilities, and proceed with US regulatory submissions. The Surfacer System is a proprietary system that allows physicians to gain venous access using a novel approach.

2013

Bluegrass Vascular Technologies Presents Positive Early Results for First In Human Study

January 22, 2013

Bluegrass Vascular Technologies presented initial first in human results for the Surfacer™ Inside-Out™ Access Catheter System in the poster session today at the 25th Annual International Symposium on Endovascular Therapy (ISET) in Miami Beach, FL. A total of six patients with severe renal disease and upper extremity occlusive disease were treated with 100 percent acute success rate in accessing occluded vessels, maintaining patient safety, and access potency.

2011

Bluegrass Vascular Technologies Begins First Clinical Study of the Surfacer® Inside-Out™ Access Catheter System

December 9, 2011

Bluegrass Vascular Technologies has announced patient enrollment in the first clinical study of its Surfacer™ Inside-Out Access Catheter System, a proprietary system that allows physicians to perform a novel approach to gain venous access. The prospective single-center feasibility study will evaluate the safety and effectiveness of the Surfacer in up to 10 patients with upper extremity venous occlusion (or blockage in the vein). Conducted by Principal Investigator Dr. Adrian Ebner at the Sanitorio Italiano in Asunción, Paraguay, the study commenced with the successful treatment of six patients in early December.

Therix Medical Spins Out Bluegrass Vascular Technologies, Developer of the Surfacer® Inside-Out™ Access Catheter System

November 15, 2011

Medical technology incubator Therix Medical has announced the launch of spin-out Bluegrass Vascular Technologies, a stand-alone company dedicated to developing and commercializing life-saving devices and methods that address shortcomings in vascular access procedures. Bluegrass Vascular Technologies’ flagship product is the Surfacer® Inside-Out™Access Catheter System, a proprietary instrumentation set that allows physicians to perform a novel femoral approach to gain venous access.